Wenyuan Zhou

State Key Laboratory Of Holistic Integrative Management Of Gastrointestinal Cancers, Beijing Key Laboratory Of Carcinogenesis And Translational Research, NMPA Key Laboratory For Research And Evaluation Of Radiopharmaceuticals
Beijing, 100142, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Targeting RRM2 with dual-modal theranostic smart nanoresponder overcomes osimertinib resistance and triggers immune remodeling in NSCLC.

Targeting RRM2 with dual-modal theranostic smart nanoresponder overcomes osimertinib resistance and triggers immune remodeling in NSCLC.

Journal: Science advances

Published: October 17, 2025

Predicting 177Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Predicting 177Lu-DOTATATE therapy response through immune microenvironment parameters in gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Journal: European journal of nuclear medicine and molecular imaging

Published: March 21, 2025

A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies.

A whole-body imaging technique for tumor-specific diagnostics and screening of B7H3-targeted therapies.

Journal: The Journal of clinical investigation

Published: January 23, 2025

Novel Peptide-Based 68Ga-Labeled Radiotracer for Preclinical Studies of TIM3 Expression.

Novel Peptide-Based 68Ga-Labeled Radiotracer for Preclinical Studies of TIM3 Expression.

Journal: Molecular pharmaceutics

Published: November 08, 2024

Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy.

Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy.

Journal: ACS nano

Published: October 30, 2024

Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer.

Radioiodinated Nanobody immunoPET probe for in vivo detection of CD147 in pan-cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 30, 2024

YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis.

YAP inhibition overcomes adaptive resistance in HER2-positive gastric cancer treated with trastuzumab via the AKT/mTOR and ERK/mTOR axis.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: March 04, 2024

Construction and Preclinical Evaluation of 124I/125I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3.

Construction and Preclinical Evaluation of 124I/125I-Labeled Antibody Targeting T Cell Immunoglobulin and Mucin Domain-3.

Journal: Molecular pharmaceutics

Published: January 25, 2024

Somatostatin Receptor Imaging in Mice with Difference Positive Rate of SSTR2.

Somatostatin Receptor Imaging in Mice with Difference Positive Rate of SSTR2.

Journal: Neuroendocrinology

Published: May 19, 2023

A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.

A pyroptosis-related gene expression signature predicts immune microenvironment and prognosis in head and neck squamous cell carcinoma.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: March 31, 2023

Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging.

Preclinical evaluation and pilot clinical study of [68Ga]Ga-THP-APN09, a novel PD-L1 targeted nanobody radiotracer for rapid one-step radiolabeling and PET imaging.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 27, 2023

The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma.

The BRD4 inhibitor JQ1 augments the antitumor efficacy of abemaciclib in preclinical models of gastric carcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 21, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026